allopurinol/glavobol

Povezava se shrani v odložišče

Izberite vrsto razvrščanja

Stran 1 iz 18 rezultatov

Allopurinol in the treatment of zoonotic cutaneous leishmaniasis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Twenty male patients with zoonotic cutaneous leishmaniasis were included in this study. Each patient received 1200 mg of allopurinol/day in divided doses for a duration of one month. 80% of patients had an excellent response (cure), however, sometimes leaving mild pigmented or faintly coloured skin

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE To assess the efficacy and tolerability of lesinurad, an oral selective uric acid reabsorption inhibitor, in combination with allopurinol versus allopurinol alone in patients with gout and an inadequate response to allopurinol. METHODS Patients (N=227) with an inadequate response to

Allopurinol and loss of consciousness in a 78-old year man suffering from gout.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Allopurinol is an FDA-Approved xanthine oxidase inhibitor that uses in the treatment of gout, hyperuricemia and uremic kidney stones in the patients with an increased level of uric acid excretion. Xanthine oxidase acts by converting hypoxanthine and xanthine to uric acid, and therefore its

Another Emergent Cause of Headache.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

We present a case of a subacute headache related to leukostasis secondary to accelerated chronic myeloid leukemia (CML), which required white blood cell (WBC) reduction in the emergency department. A 28-year-old male presented to the emergency department with a chronic headache found to be secondary

Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

To assess the utility and tolerability of thiopurine-allopurinol co-therapy in inflammatory bowel disease (IBD) patients with intolerance to thiopurine monotherapy. A retrospective observational study assessed cases of thiopurine intolerance then switched to thiopurine allopurinol co-therapy between

[Intraventricular hemorrhage due to the rupture of atherosclerotic dissecting aneurysm of the middle cerebral artery].

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND We present a case of fusiform intracranial aneurysm where, apart from the unusual site, we draw attention to the form of clinical presentation, namely intraventricular haemorrhage. Clinical case. A 68 year-old-man with a history of smoking, hyperuricemia with seizures of gout treated with

Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

OBJECTIVE To review the pharmacology, pharmacokinetics, clinical trial data, safety profile, precautions, and place in therapy of febuxostat, a novel nonpurine xanthine oxidase inhibitor in development for the treatment of hyperuricemia and gout. METHODS Available studies and abstracts were

Febuxostat for prevention of gout attacks.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

(1) Febuxostat is a selective inhibitor of xanthine oxidase. Its use in the management of hyperuricemia and gout is being studied. (2) In a 52-week, phase III randomized clinical trial, febuxostat was superior to allopurinol for lowering uric acid levels. Its efficacy in preventing gout attacks was

The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Xanthine oxidase inhibitors are commonly used to lower uric acid levels in patients with gout. Due to their effects on endothelial function, they have also been investigated for possible benefits for patients with cardiovascular disease. OBJECTIVE To assess the efficacy and safety of

Phase I study of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

A phase I trial of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NCS 286193, tiazofurin) was conducted using a 5-day i.v. bolus schedule, every 21 days. Thirty one patients with advanced cancer were entered on the trial. A total of 106 cycles were administered with doses ranging from 550 to 2750

Acute lymphoblastic leukemia presenting as acute renal failure.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND A 42-year-old previously healthy man presented with acute-onset headache and facial paralysis. He was treated for Bell's palsy with corticosteroids and valaciclovir. One week later, he developed acute renal failure requiring hospitalization. METHODS Physical examination, laboratory tests,

Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluation.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Tiazofurin is a novel C-nucleoside with significant antitumor activity in murine tumor models. In a phase I clinical trial, patients received tiazofurin by bolus iv infusion daily for 5 days. Six doses ranging from 550 to 4100 mg/m2/day were evaluated. Thirty-one treatment courses were initiated in

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Pouchitis occurs in approximately 50% of patients following ileal pouch-anal anastomosis (IPAA) for chronic ulcerative colitis (UC).The primary objective was to determine the efficacy and safety of medical therapies for prevention or treatment of acute or

Febuxostat: a new treatment for hyperuricaemia in gout.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Febuxostat is a new non-purine xanthine oxidase inhibitor that is more potent than allopurinol 300 mg daily. In two Phase III trials, significantly more febuxostat-treated gout patients met the primary endpoint [serum urate (sUA) <6 mg/dl (<360 mumol/l) at the last three visits] (48 and 53% with 80

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Prejšnji
1
2
Naslednji

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah